AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $2.25 billion. The enterprise value is $1.89 billion.
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 305.38 million shares outstanding. The number of shares has increased by 1.52% in one year.
| Current Share Class | 305.38M |
| Shares Outstanding | 305.38M |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 22.93% |
| Owned by Institutions (%) | 28.67% |
| Float | 205.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.45 |
| Forward PS | 70.81 |
| PB Ratio | 2.39 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.05, with a Debt / Equity ratio of 0.15.
| Current Ratio | 14.05 |
| Quick Ratio | 12.29 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.68% and return on invested capital (ROIC) is -36.87%.
| Return on Equity (ROE) | -14.68% |
| Return on Assets (ROA) | -9.99% |
| Return on Invested Capital (ROIC) | -36.87% |
| Return on Capital Employed (ROCE) | -16.82% |
| Weighted Average Cost of Capital (WACC) | 10.20% |
| Revenue Per Employee | $140,940 |
| Profits Per Employee | -$256,149 |
| Employee Count | 562 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -30.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.21% in the last 52 weeks. The beta is 1.20, so ABCL's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +94.21% |
| 50-Day Moving Average | 5.03 |
| 200-Day Moving Average | 4.31 |
| Relative Strength Index (RSI) | 73.40 |
| Average Volume (20 Days) | 7,364,753 |
Short Selling Information
The latest short interest is 47.12 million, so 15.43% of the outstanding shares have been sold short.
| Short Interest | 47.12M |
| Short Previous Month | 42.95M |
| Short % of Shares Out | 15.43% |
| Short % of Float | 22.98% |
| Short Ratio (days to cover) | 4.99 |
Income Statement
In the last 12 months, ABCL had revenue of $79.21 million and -$143.96 million in losses. Loss per share was -$0.48.
| Revenue | 79.21M |
| Gross Profit | -111.79M |
| Operating Income | -211.96M |
| Pretax Income | -174.15M |
| Net Income | -143.96M |
| EBITDA | -188.28M |
| EBIT | -211.96M |
| Loss Per Share | -$0.48 |
Full Income StatementBalance Sheet
The company has $504.73 million in cash and $140.18 million in debt, giving a net cash position of $364.55 million or $1.19 per share.
| Cash & Cash Equivalents | 504.73M |
| Total Debt | 140.18M |
| Net Cash | 364.55M |
| Net Cash Per Share | $1.19 |
| Equity (Book Value) | 938.08M |
| Book Value Per Share | 3.09 |
| Working Capital | 617.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$153.26 million and capital expenditures -$35.97 million, giving a free cash flow of -$189.23 million.
| Operating Cash Flow | -153.26M |
| Capital Expenditures | -35.97M |
| Depreciation & Amortization | 23.68M |
| Net Borrowing | 30.95M |
| Free Cash Flow | -189.23M |
| FCF Per Share | -$0.62 |
Full Cash Flow StatementMargins
Gross margin is -141.13%, with operating and profit margins of -267.60% and -181.74%.
| Gross Margin | -141.13% |
| Operating Margin | -267.60% |
| Pretax Margin | -219.86% |
| Profit Margin | -181.74% |
| EBITDA Margin | -237.71% |
| EBIT Margin | -267.60% |
| FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.52% |
| Shareholder Yield | -1.52% |
| Earnings Yield | -6.39% |
| FCF Yield | -8.40% |
Analyst Forecast
The average price target for ABCL is $10.43, which is 41.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.43 |
| Price Target Difference | 41.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | -23.71% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 1.84 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 3 |